文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

橙皮苷对重症急性胰腺炎大鼠的治疗作用及其机制

[Therapeutic effect of hesperidin on severe acute pancreatitis in rats and its mechanism].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2017-01-01
一句话结论大鼠SAP模型中,橙皮苷10 mg/kg与20 mg/kg静脉注射可提高24小时生存率、减轻胰腺损伤并抑制TLR4/IRAK1/NF-κB通路。

该研究将60只雄性SD大鼠随机分为5组(每组12只):假手术组、SAP模型组、地塞米松组(5 mg/kg)、橙皮苷低剂量组(10 mg/kg)和高剂量组(20 mg/kg)。SAP通过胆胰管逆行注入3.5%牛磺胆酸钠溶液诱导,假手术组注入等量生理盐水,各组于术后5分钟经股静脉注射相应药物。24小时后观察生存率、血清淀粉酶、腹水量、胰腺相对比重、胰腺病理改变及血清和胰腺组织IL-1β、IL-6、TNF-α水平,并检测TLR4表达及IRAK1、NF-κB磷酸化水平。结果显示橙皮苷低、高剂量组24小时生存率分别为83.3%、100%,高于SAP模型组的58.3%,腹水量、血清淀粉酶、胰腺相对比重及炎症因子水平均降低,TLR4/IRAK1/NF-κB通路表达受抑(均P<0.05),高剂量橙皮苷效果更显著,地塞米松作用与高剂量橙皮苷相似。

要点

  • SAP模型组24小时生存率为58.3%,橙皮苷10 mg/kg组为83.3%、20 mg/kg组为100%,高剂量组生存率更高。
  • 橙皮苷低、高剂量组腹水量分别为7.36±0.91 mL、6.10±1.02 mL,均低于SAP模型组的13.82±2.06 mL。
  • 橙皮苷低、高剂量组血清淀粉酶分别为1081.48±78.23 U/L、1048.58±49.97 U/L,均低于SAP模型组的1990.37±127.27 U/L。
  • 高剂量橙皮苷组血清IL-1β、IL-6、TNF-α分别为68.08±10.49 ng/L、63.88±10.47 ng/L、10.42±1.49 ng/L,均低于SAP模型组的130.30±23.35 ng/L、158.41±21.38 ng/L、18.16±2.01 ng/L。
  • 橙皮苷低、高剂量组TLR4/β-actin分别为91.9±15.6、83.7±11.2,均低于SAP模型组的168.5±9.0(假手术组为100),p-IRAK1/IRAK1和p-NF-κB p65/NF-κB p65亦降低(均P<0.05)。

适用人群与场景

  • 雄性Sprague-Dawley(SD)大鼠,共60只,每组12只,用于诱导重症急性胰腺炎(SAP)模型。
  • SAP模型通过胆胰管逆行注入3.5%牛磺胆酸钠溶液诱导;假手术组注入等量生理盐水。

处置流程与药物剂量

  • 橙皮苷低剂量组:10 mg/kg,于术后5分钟经股静脉注射。
  • 橙皮苷高剂量组:20 mg/kg,于术后5分钟经股静脉注射。
  • 地塞米松组:5 mg/kg,于术后5分钟经股静脉注射。

研究设计与关键结果

  • 研究类型:动物实验;60只雄性SD大鼠随机分为5组(每组12只):假手术组、SAP模型组、地塞米松组(5 mg/kg)、橙皮苷低剂量组(10 mg/kg)和高剂量组(20 mg/kg);干预为术后5分钟经股静脉注射,24小时后评估。
  • 24小时生存率:橙皮苷低剂量组83.3%、高剂量组100%,均高于SAP模型组的58.3%。
  • 腹水量:橙皮苷低剂量组7.36±0.91 mL、高剂量组6.10±1.02 mL,均低于SAP模型组的13.82±2.06 mL。
  • 血清淀粉酶:橙皮苷低剂量组1081.48±78.23 U/L、高剂量组1048.58±49.97 U/L,均低于SAP模型组的1990.37±127.27 U/L。
  • 胰腺相对比重:橙皮苷低剂量组(7.52±1.02)%、高剂量组(5.59±0.96)%,均低于SAP模型组的(11.22±0.96)%。
  • 高剂量橙皮苷组血清IL-1β 68.08±10.49 ng/L vs SAP模型组130.30±23.35 ng/L;IL-6 63.88±10.47 ng/L vs 158.41±21.38 ng/L;TNF-α 10.42±1.49 ng/L vs 18.16±2.01 ng/L;胰腺组织IL-1β 13.87±1.84 pg/μg vs 20.08±1.66 pg/μg;IL-6 21.90±3.12 pg/μg vs 38.13±3.57 pg/μg;TNF-α 1.88±0.20 pg/μg vs 4.26±0.58 pg/μg。
  • TLR4/β-actin:橙皮苷低剂量组91.9±15.6、高剂量组83.7±11.2,均低于SAP模型组的168.5±9.0(假手术组为100);p-IRAK1/IRAK1:低剂量组117.4±7.6、高剂量组104.7±11.5 vs SAP模型组173.5±15.8;p-NF-κB p65/NF-κB p65:低剂量组119.9±9.3、高剂量组105.8±12.6 vs SAP模型组174.1±13.0;差异均有统计学意义(均P<0.05)。
  • 地塞米松组效果与高剂量橙皮苷组相似。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠SAP模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在大鼠SAP模型中,橙皮苷10 mg/kg与20 mg/kg静脉注射可提高24小时生存率、减少腹水、降低血清淀粉酶和胰腺相对比重、减轻胰腺病理损伤,并抑制TLR4/IRAK1/NF-κB通路及炎症因子表达。
  • 作者认为橙皮苷对SAP大鼠具有显著保护作用,高剂量(20 mg/kg)效果更显著。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the protective effect of hesperidin on severe acute pancreatitis (SAP) in rats and its related mechanism.

METHODS: Sixty male Sprague-Dawley (SD) rats were randomly divided into five groups (n = 12 in each group): sham group, SAP model group, dexamethasone group (5 mg/kg), low and high dose of hesperidin groups (10 mg/kg and 20 mg/kg). SAP rats were administered a retrograde infusion of 3.5% sodium taurocholate solution into the biliopancreatic duct after laparotomy. Sham rats were administered with equivalent saline. The treatment was intravenously injected 5 minutes after operation through femoral vein. After 24 hours, the survival of animals was observed, the level of serum amylase, the volume of ascites and the relative specific gravity of the pancreas were measured; the pathological changes of pancreatic tissue were observed by Hematoxylin-eosin (HE) staining; the levels of serum and pancreatic tissue interleukin (IL-1β, IL-6) and tumor necrosis factor-α (TNF-α) were detected by enzyme linked immunosorbent assay (ELISA); the expression of Toll-like receptor 4 (TLR4), the phosphorylation of IL-1 receptor associated kinase (IRAK1) and nuclear factor-κB (NF-κB) were detected by Western Blot.

RESULTS: Compared with SAP model group, the 24-hour survival rate were increased in low and high dose of hesperidin groups (83.3%, 100% vs. 58.3%), the volume of ascites were reduced (mL: 7.36±0.91, 6.10±1.02 vs. 13.82±2.06), the levels of serum amylase were reduced (U/L: 1 081.48±78.23, 1 048.58±49.97 vs. 1 990.37±127.27), the relative specific gravity of the pancreas were reduced [(7.52±1.02)%, (5.59±0.96)% vs. (11.22±0.96)%], and the pathological damage of pancreatic tissue were reduced; the levels of serum and pancreatic tissue inflammatory factors were reduced in high dose hesperidin group [serum IL-1β (ng/L): 68.08±10.49 vs. 130.30±23.35, IL-6 (ng/L): 63.88±10.47 vs. 158.41±21.38, TNF-α (ng/L): 10.42±1.49 vs. 18.16±2.01; pancreas IL-1β (pg/μg): 13.87±1.84 vs. 20.08±1.66, IL-6 (pg/μg): 21.90±3.12 vs. 38.13±3.57, TNF-α (pg/μg): 1.88±0.20 vs. 4.26±0.58]; the expression of TLR4, and the phosphorylation levels of IRAK1 and NF-κB were decreased in low and high dose of hesperidin groups (the sham operation group was 100, TLR4/β-actin: 91.9±15.6, 83.7±11.2 vs. 168.5±9.0, p-IRAK1/IRAK1: 117.4±7.6, 104.7±11.5 vs. 173.5±15.8, p-NF-κB p65/NF-κB p65: 119.9±9.3, 105.8±12.6 vs. 174.1±13.0), with statistically significant differences (all P < 0.05). The effects of dexamethasone were similar to that of high dose of hesperidin.

CONCLUSIONS: Hesperidin could significantly protect SAP rats, and this protection was related to the inhibition of TLR4/IRAK1/NF-κB signaling pathway, and to the reduction of pro-inflammatory cytokine expressions. The effect of high dose hesperidin (20 mg/kg) was more significant.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Li M, Guo Z, Shao H, et al. [Therapeutic effect of hesperidin on severe acute pancreatitis in rats and its mechanism]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017. PMID: 29017654. doi:10.3760/cma.j.issn.2095-4352.2017.10.012

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。